

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine metabolic process (GO:0006558) | 5.82682860 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.82682860 |
| 3 | L-phenylalanine catabolic process (GO:0006559) | 5.78418306 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.78418306 |
| 5 | negative regulation of erythrocyte differentiation (GO:0045647) | 5.77823627 |
| 6 | alpha-linolenic acid metabolic process (GO:0036109) | 5.06596575 |
| 7 | L-serine metabolic process (GO:0006563) | 4.66635108 |
| 8 | protein carboxylation (GO:0018214) | 4.56364218 |
| 9 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.56364218 |
| 10 | aromatic amino acid family catabolic process (GO:0009074) | 4.32321374 |
| 11 | serine family amino acid biosynthetic process (GO:0009070) | 4.10509578 |
| 12 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.09205935 |
| 13 | negative regulation of sterol transport (GO:0032372) | 3.91326051 |
| 14 | negative regulation of cholesterol transport (GO:0032375) | 3.91326051 |
| 15 | response to muramyl dipeptide (GO:0032495) | 3.83494262 |
| 16 | regulation of ARF GTPase activity (GO:0032312) | 3.81865223 |
| 17 | negative regulation of fibrinolysis (GO:0051918) | 3.80195302 |
| 18 | urea cycle (GO:0000050) | 3.78819936 |
| 19 | urea metabolic process (GO:0019627) | 3.78819936 |
| 20 | regulation of fibrinolysis (GO:0051917) | 3.69362275 |
| 21 | bile acid biosynthetic process (GO:0006699) | 3.68298660 |
| 22 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.59363860 |
| 23 | regulation of cholesterol homeostasis (GO:2000188) | 3.54715937 |
| 24 | sulfur amino acid catabolic process (GO:0000098) | 3.53818949 |
| 25 | plasma lipoprotein particle clearance (GO:0034381) | 3.51468605 |
| 26 | high-density lipoprotein particle remodeling (GO:0034375) | 3.50799658 |
| 27 | positive thymic T cell selection (GO:0045059) | 3.46813439 |
| 28 | cell-cell junction maintenance (GO:0045217) | 3.46362939 |
| 29 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.43816337 |
| 30 | bile acid metabolic process (GO:0008206) | 3.36842119 |
| 31 | tyrosine metabolic process (GO:0006570) | 3.34669616 |
| 32 | complement activation, alternative pathway (GO:0006957) | 3.33231790 |
| 33 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.32395201 |
| 34 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.32395201 |
| 35 | lysine catabolic process (GO:0006554) | 3.31929129 |
| 36 | lysine metabolic process (GO:0006553) | 3.31929129 |
| 37 | kynurenine metabolic process (GO:0070189) | 3.31479080 |
| 38 | glyoxylate metabolic process (GO:0046487) | 3.28997107 |
| 39 | regulation of protein activation cascade (GO:2000257) | 3.26270861 |
| 40 | glycine metabolic process (GO:0006544) | 3.25002027 |
| 41 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 3.23242212 |
| 42 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.23103559 |
| 43 | Golgi transport vesicle coating (GO:0048200) | 3.22556214 |
| 44 | COPI coating of Golgi vesicle (GO:0048205) | 3.22556214 |
| 45 | protein retention in ER lumen (GO:0006621) | 3.22067038 |
| 46 | nitrogen cycle metabolic process (GO:0071941) | 3.18624947 |
| 47 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.18526219 |
| 48 | tetrahydrofolate metabolic process (GO:0046653) | 3.18485067 |
| 49 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.17590649 |
| 50 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.13868608 |
| 51 | negative regulation of cell size (GO:0045792) | 3.13065989 |
| 52 | negative regulation of cell killing (GO:0031342) | 3.13043472 |
| 53 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.13043472 |
| 54 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.12527325 |
| 55 | regulation of ARF protein signal transduction (GO:0032012) | 3.10682305 |
| 56 | axon extension involved in axon guidance (GO:0048846) | 3.09117439 |
| 57 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 3.09117439 |
| 58 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.08635558 |
| 59 | cellular modified amino acid catabolic process (GO:0042219) | 3.08288225 |
| 60 | thymic T cell selection (GO:0045061) | 3.05985080 |
| 61 | regulation of extracellular matrix disassembly (GO:0010715) | 3.05735767 |
| 62 | mannose metabolic process (GO:0006013) | 3.01782836 |
| 63 | plasma lipoprotein particle remodeling (GO:0034369) | 3.01722206 |
| 64 | protein-lipid complex remodeling (GO:0034368) | 3.01722206 |
| 65 | macromolecular complex remodeling (GO:0034367) | 3.01722206 |
| 66 | regulation of complement activation (GO:0030449) | 3.01615230 |
| 67 | aromatic amino acid family metabolic process (GO:0009072) | 2.99291828 |
| 68 | tryptophan metabolic process (GO:0006568) | 2.98406395 |
| 69 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.97900641 |
| 70 | 4-hydroxyproline metabolic process (GO:0019471) | 2.97900556 |
| 71 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.96274330 |
| 72 | tryptophan catabolic process (GO:0006569) | 2.96147414 |
| 73 | indole-containing compound catabolic process (GO:0042436) | 2.96147414 |
| 74 | indolalkylamine catabolic process (GO:0046218) | 2.96147414 |
| 75 | glutamate metabolic process (GO:0006536) | 2.96140293 |
| 76 | histone H4 deacetylation (GO:0070933) | 2.95323434 |
| 77 | modulation by virus of host process (GO:0019054) | 2.94410282 |
| 78 | semaphorin-plexin signaling pathway (GO:0071526) | 2.94146425 |
| 79 | fatty acid elongation (GO:0030497) | 2.92907915 |
| 80 | positive regulation of histone deacetylation (GO:0031065) | 2.91381875 |
| 81 | aspartate family amino acid catabolic process (GO:0009068) | 2.91317156 |
| 82 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.90681418 |
| 83 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.90681418 |
| 84 | modulation by symbiont of host immune response (GO:0052553) | 2.90681418 |
| 85 | positive regulation by symbiont of host defense response (GO:0052509) | 2.90681418 |
| 86 | modulation by symbiont of host defense response (GO:0052031) | 2.90681418 |
| 87 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.90681418 |
| 88 | acetyl-CoA metabolic process (GO:0006084) | 2.89966989 |
| 89 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.88856443 |
| 90 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.87232046 |
| 91 | reverse cholesterol transport (GO:0043691) | 2.86945074 |
| 92 | endothelial cell chemotaxis (GO:0035767) | 2.86463439 |
| 93 | positive regulation of lipid catabolic process (GO:0050996) | 2.85407741 |
| 94 | alpha-amino acid catabolic process (GO:1901606) | 2.84437281 |
| 95 | positive regulation of nuclease activity (GO:0032075) | 2.82868730 |
| 96 | proline biosynthetic process (GO:0006561) | 2.82834664 |
| 97 | response to methylmercury (GO:0051597) | 2.82728737 |
| 98 | modulation by symbiont of host cellular process (GO:0044068) | 2.82030418 |
| 99 | acylglycerol homeostasis (GO:0055090) | 2.81301560 |
| 100 | triglyceride homeostasis (GO:0070328) | 2.81301560 |
| 101 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.80437884 |
| 102 | protein-lipid complex assembly (GO:0065005) | 2.80016579 |
| 103 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.78076054 |
| 104 | regulation of monocyte differentiation (GO:0045655) | 2.78016870 |
| 105 | serine family amino acid metabolic process (GO:0009069) | 2.77081595 |
| 106 | phospholipid efflux (GO:0033700) | 2.76519253 |
| 107 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.75123238 |
| 108 | coenzyme catabolic process (GO:0009109) | 2.74547005 |
| 109 | regulation of cholesterol esterification (GO:0010872) | 2.73806049 |
| 110 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.72884898 |
| 111 | plasma lipoprotein particle assembly (GO:0034377) | 2.72351646 |
| 112 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.72030118 |
| 113 | one-carbon metabolic process (GO:0006730) | 2.71668938 |
| 114 | phospholipid homeostasis (GO:0055091) | 2.71321534 |
| 115 | cholesterol efflux (GO:0033344) | 2.70972815 |
| 116 | response to peptidoglycan (GO:0032494) | 2.70517167 |
| 117 | regulation of triglyceride catabolic process (GO:0010896) | 2.65981515 |
| 118 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.65974356 |
| 119 | apoptotic cell clearance (GO:0043277) | 2.65236646 |
| 120 | germinal center formation (GO:0002467) | 2.63665109 |
| 121 | negative regulation of lipase activity (GO:0060192) | 2.63411404 |
| 122 | activation of MAPKKK activity (GO:0000185) | 2.63268457 |
| 123 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.63139449 |
| 124 | cellular amino acid catabolic process (GO:0009063) | 2.62869498 |
| 125 | cellular response to virus (GO:0098586) | 2.62609191 |
| 126 | macroautophagy (GO:0016236) | 2.61614099 |
| 127 | positive regulation of protein deacetylation (GO:0090312) | 2.60846903 |
| 128 | folic acid-containing compound metabolic process (GO:0006760) | 2.59971787 |
| 129 | very long-chain fatty acid metabolic process (GO:0000038) | 2.59326966 |
| 130 | astrocyte differentiation (GO:0048708) | 2.58378818 |
| 131 | complement activation, classical pathway (GO:0006958) | 2.57937852 |
| 132 | response to laminar fluid shear stress (GO:0034616) | 2.57853555 |
| 133 | low-density lipoprotein particle remodeling (GO:0034374) | 2.57173268 |
| 134 | positive regulation of gastrulation (GO:2000543) | 2.57011921 |
| 135 | detection of bacterium (GO:0016045) | 2.54990282 |
| 136 | negative regulation of granulocyte differentiation (GO:0030853) | 2.54169721 |
| 137 | negative regulation of cell cycle arrest (GO:0071157) | 2.53874480 |
| 138 | retrograde transport, endosome to Golgi (GO:0042147) | 2.53718016 |
| 139 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.53657720 |
| 140 | apoptotic process involved in morphogenesis (GO:0060561) | 2.53198568 |
| 141 | negative thymic T cell selection (GO:0045060) | 2.53151336 |
| 142 | activation of JUN kinase activity (GO:0007257) | 2.52317508 |
| 143 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.51354501 |
| 144 | mitochondrion transport along microtubule (GO:0047497) | 2.51290169 |
| 145 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.51290169 |
| 146 | cell junction maintenance (GO:0034331) | 2.51189817 |
| 147 | entrainment of circadian clock by photoperiod (GO:0043153) | 2.50295730 |
| 148 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.49302677 |
| 149 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.48613317 |
| 150 | regulation of cholesterol metabolic process (GO:0090181) | 2.47293659 |
| 151 | regulation of extracellular matrix organization (GO:1903053) | 2.45103964 |
| 152 | NIK/NF-kappaB signaling (GO:0038061) | 2.44505855 |
| 153 | regulation of gamma-delta T cell activation (GO:0046643) | 2.44323760 |
| 154 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.44322625 |
| 155 | positive regulation of extracellular matrix organization (GO:1903055) | 2.44063835 |
| 156 | histone H3 deacetylation (GO:0070932) | 2.43530019 |
| 157 | maintenance of protein localization in organelle (GO:0072595) | 2.42830757 |
| 158 | detection of other organism (GO:0098543) | 2.37400993 |
| 159 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.37270337 |
| 160 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.35500931 |
| 161 | UV protection (GO:0009650) | 2.32254565 |
| 162 | protein kinase C signaling (GO:0070528) | 2.32042815 |
| 163 | negative regulation of innate immune response (GO:0045824) | 2.30680619 |
| 164 | T cell selection (GO:0045058) | 2.30207847 |
| 165 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.28792022 |
| 166 | regulation of leukocyte degranulation (GO:0043300) | 2.28391203 |
| 167 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.28185188 |
| 168 | establishment of mitochondrion localization (GO:0051654) | 2.27512654 |
| 169 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.27452136 |
| 170 | positive regulation of protein kinase C signaling (GO:0090037) | 2.27394255 |
| 171 | immunoglobulin mediated immune response (GO:0016064) | 2.26819378 |
| 172 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.24569198 |
| 173 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.23959954 |
| 174 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.23093766 |
| 175 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.23093766 |
| 176 | regulation of apoptotic cell clearance (GO:2000425) | 2.23083135 |
| 177 | receptor catabolic process (GO:0032801) | 2.22453986 |
| 178 | phosphatidylglycerol biosynthetic process (GO:0006655) | 2.21914914 |
| 179 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.20548541 |
| 180 | macrophage activation involved in immune response (GO:0002281) | 2.20381467 |
| 181 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.20375749 |
| 182 | leukocyte aggregation (GO:0070486) | 2.20268437 |
| 183 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.20255677 |
| 184 | chondroitin sulfate catabolic process (GO:0030207) | 2.19414150 |
| 185 | regulation of histone deacetylation (GO:0031063) | 2.19092894 |
| 186 | positive T cell selection (GO:0043368) | 2.18797507 |
| 187 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.17955201 |
| 188 | histone H3-K9 demethylation (GO:0033169) | 2.17749742 |
| 189 | negative T cell selection (GO:0043383) | 2.17142505 |
| 190 | cell migration in hindbrain (GO:0021535) | 2.16897947 |
| 191 | cell volume homeostasis (GO:0006884) | 2.16881542 |
| 192 | positive regulation of Rap GTPase activity (GO:0032854) | 2.16824655 |
| 193 | signal complex assembly (GO:0007172) | 2.16592698 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.01705614 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.76346398 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.38225146 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.63823821 |
| 5 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.09981049 |
| 6 | MYC_22102868_ChIP-Seq_BL_Human | 3.03958971 |
| 7 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.99151222 |
| 8 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.83587081 |
| 9 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.81747589 |
| 10 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.59252831 |
| 11 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.53768450 |
| 12 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.38942872 |
| 13 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.35037085 |
| 14 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.27613086 |
| 15 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.26898650 |
| 16 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 2.24372693 |
| 17 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.23905573 |
| 18 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.08969964 |
| 19 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.03092267 |
| 20 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.01031252 |
| 21 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.00027364 |
| 22 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.98702742 |
| 23 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.94481286 |
| 24 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.94066480 |
| 25 | P68_20966046_ChIP-Seq_HELA_Human | 1.93381084 |
| 26 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.91328624 |
| 27 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.90746439 |
| 28 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.89552959 |
| 29 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.87763963 |
| 30 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.87224998 |
| 31 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.86435442 |
| 32 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.84633881 |
| 33 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.84334739 |
| 34 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.79273895 |
| 35 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.78375654 |
| 36 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.78187299 |
| 37 | SPI1_23127762_ChIP-Seq_K562_Human | 1.74278563 |
| 38 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.70526907 |
| 39 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.70387367 |
| 40 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.69774020 |
| 41 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.67940694 |
| 42 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.67774721 |
| 43 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.67342464 |
| 44 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.66519748 |
| 45 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.65622323 |
| 46 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.63394745 |
| 47 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.62827744 |
| 48 | MAF_26560356_Chip-Seq_TH1_Human | 1.59573990 |
| 49 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.58973382 |
| 50 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.58904480 |
| 51 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.57334287 |
| 52 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.55509850 |
| 53 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.54278911 |
| 54 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.50642515 |
| 55 | UTX_26944678_Chip-Seq_JUKART_Human | 1.48904070 |
| 56 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.48680150 |
| 57 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.48583550 |
| 58 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.47223586 |
| 59 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.47156754 |
| 60 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45615869 |
| 61 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.41595433 |
| 62 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.39042344 |
| 63 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.38743737 |
| 64 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.37757701 |
| 65 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.35534657 |
| 66 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.35120018 |
| 67 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.35018858 |
| 68 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.34093161 |
| 69 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.33567025 |
| 70 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.33190691 |
| 71 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.33094875 |
| 72 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.32504395 |
| 73 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.32421196 |
| 74 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.32141404 |
| 75 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.30119107 |
| 76 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.29038411 |
| 77 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.28821224 |
| 78 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.26553947 |
| 79 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.24494256 |
| 80 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.23846387 |
| 81 | MAF_26560356_Chip-Seq_TH2_Human | 1.22847240 |
| 82 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.22645889 |
| 83 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.21273876 |
| 84 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.20584245 |
| 85 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.20462389 |
| 86 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.19799935 |
| 87 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.19212769 |
| 88 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.18926761 |
| 89 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.18795851 |
| 90 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.17943203 |
| 91 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.17713544 |
| 92 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.17713515 |
| 93 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.17558651 |
| 94 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.17400662 |
| 95 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.17376290 |
| 96 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.17019937 |
| 97 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.12911783 |
| 98 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.11655375 |
| 99 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.11010633 |
| 100 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.11003720 |
| 101 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.09324830 |
| 102 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.09206341 |
| 103 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.09056105 |
| 104 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.08565998 |
| 105 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.08525132 |
| 106 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.08160973 |
| 107 | SA1_27219007_Chip-Seq_Bcells_Human | 1.07384996 |
| 108 | MYB_26560356_Chip-Seq_TH1_Human | 1.07089209 |
| 109 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.05318683 |
| 110 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.05201250 |
| 111 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.04991822 |
| 112 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.04810589 |
| 113 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.04651077 |
| 114 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.04449378 |
| 115 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.03419637 |
| 116 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.02787372 |
| 117 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.01606611 |
| 118 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.01021558 |
| 119 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00183050 |
| 120 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.99698052 |
| 121 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99576127 |
| 122 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.99447282 |
| 123 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.99138254 |
| 124 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.98861288 |
| 125 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.97404600 |
| 126 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.93782789 |
| 127 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.92909808 |
| 128 | MYB_26560356_Chip-Seq_TH2_Human | 0.92273913 |
| 129 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.91908516 |
| 130 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.91735813 |
| 131 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.91174502 |
| 132 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.90661904 |
| 133 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.90045583 |
| 134 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.89874595 |
| 135 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.89070458 |
| 136 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.88927676 |
| 137 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88242843 |
| 138 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.87980759 |
| 139 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.86471729 |
| 140 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.86233522 |
| 141 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.85953564 |
| 142 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.85153128 |
| 143 | KDM2B_26808549_Chip-Seq_K562_Human | 0.84636662 |
| 144 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.83935588 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.07361050 |
| 2 | MP0005360_urolithiasis | 4.76663193 |
| 3 | MP0005365_abnormal_bile_salt | 4.23055029 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 3.17957011 |
| 5 | MP0009840_abnormal_foam_cell | 2.94850210 |
| 6 | MP0005083_abnormal_biliary_tract | 2.93895562 |
| 7 | MP0005058_abnormal_lysosome_morphology | 2.85390304 |
| 8 | MP0008438_abnormal_cutaneous_collagen | 2.78765850 |
| 9 | MP0003172_abnormal_lysosome_physiology | 2.62771274 |
| 10 | MP0000569_abnormal_digit_pigmentation | 2.60761880 |
| 11 | MP0003252_abnormal_bile_duct | 2.50561653 |
| 12 | MP0004185_abnormal_adipocyte_glucose | 2.32788987 |
| 13 | MP0001849_ear_inflammation | 2.30713304 |
| 14 | MP0008961_abnormal_basal_metabolism | 2.25980763 |
| 15 | MP0005220_abnormal_exocrine_pancreas | 2.22328676 |
| 16 | MP0008260_abnormal_autophagy | 2.14864362 |
| 17 | MP0010329_abnormal_lipoprotein_level | 2.05464316 |
| 18 | MP0003303_peritoneal_inflammation | 1.97411880 |
| 19 | MP0003705_abnormal_hypodermis_morpholog | 1.97234357 |
| 20 | MP0003300_gastrointestinal_ulcer | 1.92550493 |
| 21 | MP0003183_abnormal_peptide_metabolism | 1.88557254 |
| 22 | MP0004859_abnormal_synaptic_plasticity | 1.85688965 |
| 23 | MP0003195_calcinosis | 1.84428094 |
| 24 | MP0004858_abnormal_nervous_system | 1.80917538 |
| 25 | MP0002132_abnormal_respiratory_system | 1.76932953 |
| 26 | MP0005076_abnormal_cell_differentiation | 1.74666787 |
| 27 | MP0000604_amyloidosis | 1.74329036 |
| 28 | MP0002249_abnormal_larynx_morphology | 1.72360303 |
| 29 | MP0003283_abnormal_digestive_organ | 1.72003995 |
| 30 | MP0005451_abnormal_body_composition | 1.71890470 |
| 31 | MP0001944_abnormal_pancreas_morphology | 1.70082779 |
| 32 | MP0005332_abnormal_amino_acid | 1.62938395 |
| 33 | MP0001666_abnormal_nutrient_absorption | 1.62579324 |
| 34 | MP0000609_abnormal_liver_physiology | 1.62525762 |
| 35 | MP0003329_amyloid_beta_deposits | 1.58671627 |
| 36 | MP0008875_abnormal_xenobiotic_pharmacok | 1.56761223 |
| 37 | MP0001545_abnormal_hematopoietic_system | 1.54874128 |
| 38 | MP0005397_hematopoietic_system_phenotyp | 1.54874128 |
| 39 | MP0001835_abnormal_antigen_presentation | 1.53872863 |
| 40 | MP0003806_abnormal_nucleotide_metabolis | 1.45203919 |
| 41 | MP0003724_increased_susceptibility_to | 1.43859911 |
| 42 | MP0006082_CNS_inflammation | 1.42020413 |
| 43 | MP0003122_maternal_imprinting | 1.40506069 |
| 44 | MP0002089_abnormal_postnatal_growth/wei | 1.37834312 |
| 45 | MP0002118_abnormal_lipid_homeostasis | 1.36191671 |
| 46 | MP0002693_abnormal_pancreas_physiology | 1.35788949 |
| 47 | MP0009384_cardiac_valve_regurgitation | 1.34954256 |
| 48 | MP0002396_abnormal_hematopoietic_system | 1.32510784 |
| 49 | MP0005670_abnormal_white_adipose | 1.31777155 |
| 50 | MP0003191_abnormal_cellular_cholesterol | 1.30966903 |
| 51 | MP0003763_abnormal_thymus_physiology | 1.29685388 |
| 52 | MP0000681_abnormal_thyroid_gland | 1.28282212 |
| 53 | MP0000678_abnormal_parathyroid_gland | 1.27554987 |
| 54 | MP0009333_abnormal_splenocyte_physiolog | 1.26694484 |
| 55 | MP0001348_abnormal_lacrimal_gland | 1.26203250 |
| 56 | MP0003690_abnormal_glial_cell | 1.25673852 |
| 57 | MP0003868_abnormal_feces_composition | 1.22856963 |
| 58 | MP0003091_abnormal_cell_migration | 1.16862197 |
| 59 | MP0005623_abnormal_meninges_morphology | 1.16811529 |
| 60 | MP0002138_abnormal_hepatobiliary_system | 1.15693259 |
| 61 | MP0001800_abnormal_humoral_immune | 1.15318290 |
| 62 | MP0000685_abnormal_immune_system | 1.14365748 |
| 63 | MP0000858_altered_metastatic_potential | 1.12909928 |
| 64 | MP0001958_emphysema | 1.12115144 |
| 65 | MP0010155_abnormal_intestine_physiology | 1.11475656 |
| 66 | MP0009763_increased_sensitivity_to | 1.09527815 |
| 67 | MP0002405_respiratory_system_inflammati | 1.09203987 |
| 68 | MP0005464_abnormal_platelet_physiology | 1.08579219 |
| 69 | MP0009053_abnormal_anal_canal | 1.08278070 |
| 70 | MP0001790_abnormal_immune_system | 1.07359648 |
| 71 | MP0005387_immune_system_phenotype | 1.07359648 |
| 72 | MP0002998_abnormal_bone_remodeling | 1.07000759 |
| 73 | MP0000716_abnormal_immune_system | 1.06109196 |
| 74 | MP0002837_dystrophic_cardiac_calcinosis | 1.05761405 |
| 75 | MP0003879_abnormal_hair_cell | 1.04767532 |
| 76 | MP0002078_abnormal_glucose_homeostasis | 1.04456607 |
| 77 | MP0002928_abnormal_bile_duct | 1.03736128 |
| 78 | MP0005409_darkened_coat_color | 1.03513027 |
| 79 | MP0001299_abnormal_eye_distance/ | 1.03493340 |
| 80 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.03231189 |
| 81 | MP0002398_abnormal_bone_marrow | 1.01192678 |
| 82 | MP0000598_abnormal_liver_morphology | 1.01009086 |
| 83 | MP0003436_decreased_susceptibility_to | 1.00749544 |
| 84 | MP0005390_skeleton_phenotype | 0.97391226 |
| 85 | MP0002933_joint_inflammation | 0.95694511 |
| 86 | MP0000566_synostosis | 0.95173025 |
| 87 | MP0001873_stomach_inflammation | 0.93672337 |
| 88 | MP0009672_abnormal_birth_weight | 0.92164844 |
| 89 | MP0001243_abnormal_dermal_layer | 0.91968916 |
| 90 | MP0003075_altered_response_to | 0.91208753 |
| 91 | MP0005666_abnormal_adipose_tissue | 0.89354950 |
| 92 | MP0009278_abnormal_bone_marrow | 0.88856953 |
| 93 | MP0001502_abnormal_circadian_rhythm | 0.88513248 |
| 94 | MP0003634_abnormal_glial_cell | 0.87774602 |
| 95 | MP0002429_abnormal_blood_cell | 0.87752189 |
| 96 | MP0004808_abnormal_hematopoietic_stem | 0.87520959 |
| 97 | MP0009643_abnormal_urine_homeostasis | 0.85875131 |
| 98 | MP0002419_abnormal_innate_immunity | 0.85814282 |
| 99 | MP0003123_paternal_imprinting | 0.85387753 |
| 100 | MP0005499_abnormal_olfactory_system | 0.85247542 |
| 101 | MP0005394_taste/olfaction_phenotype | 0.85247542 |
| 102 | MP0000013_abnormal_adipose_tissue | 0.84519450 |
| 103 | MP0001346_abnormal_lacrimal_gland | 0.83784266 |
| 104 | MP0001915_intracranial_hemorrhage | 0.83688223 |
| 105 | MP0009780_abnormal_chondrocyte_physiolo | 0.83068151 |
| 106 | MP0003279_aneurysm | 0.83058285 |
| 107 | MP0005257_abnormal_intraocular_pressure | 0.82439079 |
| 108 | MP0004510_myositis | 0.81594426 |
| 109 | MP0005000_abnormal_immune_tolerance | 0.81382710 |
| 110 | MP0002723_abnormal_immune_serum | 0.80427999 |
| 111 | MP0005379_endocrine/exocrine_gland_phen | 0.79594988 |
| 112 | MP0001270_distended_abdomen | 0.79252287 |
| 113 | MP0005375_adipose_tissue_phenotype | 0.79224525 |
| 114 | MP0002932_abnormal_joint_morphology | 0.78851284 |
| 115 | MP0001533_abnormal_skeleton_physiology | 0.78552520 |
| 116 | MP0002822_catalepsy | 0.78317180 |
| 117 | MP0000003_abnormal_adipose_tissue | 0.78272319 |
| 118 | MP0000767_abnormal_smooth_muscle | 0.78075030 |
| 119 | MP0003866_abnormal_defecation | 0.78059954 |
| 120 | MP0001663_abnormal_digestive_system | 0.77962375 |
| 121 | MP0002896_abnormal_bone_mineralization | 0.77478725 |
| 122 | MP0005319_abnormal_enzyme/_coenzyme | 0.77326587 |
| 123 | MP0008469_abnormal_protein_level | 0.77277230 |
| 124 | MP0001853_heart_inflammation | 0.76187869 |
| 125 | MP0001851_eye_inflammation | 0.76050541 |
| 126 | MP0002722_abnormal_immune_system | 0.75795507 |
| 127 | MP0003453_abnormal_keratinocyte_physiol | 0.75510937 |
| 128 | MP0004272_abnormal_basement_membrane | 0.75257382 |
| 129 | MP0008569_lethality_at_weaning | 0.73342045 |
| 130 | MP0003115_abnormal_respiratory_system | 0.72053886 |
| 131 | MP0003787_abnormal_imprinting | 0.71183723 |
| 132 | MP0002166_altered_tumor_susceptibility | 0.69747901 |
| 133 | MP0002282_abnormal_trachea_morphology | 0.68184650 |
| 134 | MP0000703_abnormal_thymus_morphology | 0.67963880 |
| 135 | MP0003890_abnormal_embryonic-extraembry | 0.67956211 |
| 136 | MP0000920_abnormal_myelination | 0.67897219 |
| 137 | MP0005503_abnormal_tendon_morphology | 0.66684486 |
| 138 | MP0009642_abnormal_blood_homeostasis | 0.65479112 |
| 139 | MP0002420_abnormal_adaptive_immunity | 0.64680700 |
| 140 | MP0002452_abnormal_antigen_presenting | 0.64669950 |
| 141 | MP0004947_skin_inflammation | 0.64669649 |
| 142 | MP0005671_abnormal_response_to | 0.63917403 |
| 143 | MP0000733_abnormal_muscle_development | 0.63564971 |
| 144 | MP0001845_abnormal_inflammatory_respons | 0.62923050 |
| 145 | MP0000371_diluted_coat_color | 0.62754957 |
| 146 | MP0002971_abnormal_brown_adipose | 0.61383590 |
| 147 | MP0001819_abnormal_immune_cell | 0.61037815 |
| 148 | MP0002877_abnormal_melanocyte_morpholog | 0.60673584 |
| 149 | MP0000249_abnormal_blood_vessel | 0.59708183 |
| 150 | MP0002653_abnormal_ependyma_morphology | 0.59200901 |
| 151 | MP0005025_abnormal_response_to | 0.58309194 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.37722521 |
| 2 | Deep venous thrombosis (HP:0002625) | 4.59520407 |
| 3 | Xanthomatosis (HP:0000991) | 4.09790247 |
| 4 | Protrusio acetabuli (HP:0003179) | 3.94804025 |
| 5 | Abnormality of the common coagulation pathway (HP:0010990) | 3.88998207 |
| 6 | Hyperlipoproteinemia (HP:0010980) | 3.79829033 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 3.76819168 |
| 8 | Intrahepatic cholestasis (HP:0001406) | 3.75518853 |
| 9 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.57487326 |
| 10 | Obstructive sleep apnea (HP:0002870) | 3.52689122 |
| 11 | Ketosis (HP:0001946) | 3.09056085 |
| 12 | Hypobetalipoproteinemia (HP:0003563) | 3.04721442 |
| 13 | Papilledema (HP:0001085) | 2.95882014 |
| 14 | Hypoglycemic coma (HP:0001325) | 2.91049403 |
| 15 | Broad face (HP:0000283) | 2.90837310 |
| 16 | Neurofibrillary tangles (HP:0002185) | 2.87111420 |
| 17 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.86719763 |
| 18 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.86719763 |
| 19 | Complement deficiency (HP:0004431) | 2.85927104 |
| 20 | Systemic lupus erythematosus (HP:0002725) | 2.83087256 |
| 21 | J-shaped sella turcica (HP:0002680) | 2.80246376 |
| 22 | Stridor (HP:0010307) | 2.78057427 |
| 23 | Abnormality of the Achilles tendon (HP:0005109) | 2.77724731 |
| 24 | Hyperacusis (HP:0010780) | 2.77364740 |
| 25 | Eczematoid dermatitis (HP:0000976) | 2.76769964 |
| 26 | Hypoglycemic seizures (HP:0002173) | 2.75970915 |
| 27 | Abnormality of the intrinsic pathway (HP:0010989) | 2.74737822 |
| 28 | Thin bony cortex (HP:0002753) | 2.73149913 |
| 29 | Cerebral aneurysm (HP:0004944) | 2.72766610 |
| 30 | Premature rupture of membranes (HP:0001788) | 2.70026933 |
| 31 | Turricephaly (HP:0000262) | 2.65910482 |
| 32 | Cerebral inclusion bodies (HP:0100314) | 2.65229743 |
| 33 | Nuclear cataract (HP:0100018) | 2.63214095 |
| 34 | Cellulitis (HP:0100658) | 2.57652221 |
| 35 | Skin nodule (HP:0200036) | 2.56479825 |
| 36 | Late onset (HP:0003584) | 2.55380293 |
| 37 | Long toe (HP:0010511) | 2.50790577 |
| 38 | Broad palm (HP:0001169) | 2.47247498 |
| 39 | Polygenic inheritance (HP:0010982) | 2.46212075 |
| 40 | Achilles tendon contracture (HP:0001771) | 2.45594109 |
| 41 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.45087973 |
| 42 | Ketoacidosis (HP:0001993) | 2.44901033 |
| 43 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.42472132 |
| 44 | Mitral stenosis (HP:0001718) | 2.40181759 |
| 45 | Interstitial pulmonary disease (HP:0006530) | 2.36517757 |
| 46 | Dysostosis multiplex (HP:0000943) | 2.34234009 |
| 47 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.31417948 |
| 48 | Mucopolysacchariduria (HP:0008155) | 2.31417948 |
| 49 | Peritonitis (HP:0002586) | 2.29795193 |
| 50 | Myocardial infarction (HP:0001658) | 2.29203689 |
| 51 | Purpura (HP:0000979) | 2.26759055 |
| 52 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.25947374 |
| 53 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.25947374 |
| 54 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.25947374 |
| 55 | Increased IgE level (HP:0003212) | 2.25337580 |
| 56 | Pseudobulbar signs (HP:0002200) | 2.23372458 |
| 57 | Flat acetabular roof (HP:0003180) | 2.22875561 |
| 58 | Abnormality of the thoracic spine (HP:0100711) | 2.22365276 |
| 59 | Joint hemorrhage (HP:0005261) | 2.21763310 |
| 60 | Epidermoid cyst (HP:0200040) | 2.21046426 |
| 61 | Disproportionate tall stature (HP:0001519) | 2.20661074 |
| 62 | Gastrointestinal inflammation (HP:0004386) | 2.20514699 |
| 63 | Conjugated hyperbilirubinemia (HP:0002908) | 2.20299147 |
| 64 | Prolonged bleeding time (HP:0003010) | 2.16980263 |
| 65 | Global brain atrophy (HP:0002283) | 2.16559765 |
| 66 | Shallow orbits (HP:0000586) | 2.13980495 |
| 67 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.12187996 |
| 68 | Abnormality of the aortic arch (HP:0012303) | 2.11939151 |
| 69 | Broad distal phalanx of finger (HP:0009836) | 2.11544195 |
| 70 | Metaphyseal cupping (HP:0003021) | 2.11465192 |
| 71 | Dislocated radial head (HP:0003083) | 2.11427704 |
| 72 | Myositis (HP:0100614) | 2.10949957 |
| 73 | Abnormality of complement system (HP:0005339) | 2.09826470 |
| 74 | Joint stiffness (HP:0001387) | 2.08461784 |
| 75 | Abnormality of glycolipid metabolism (HP:0010969) | 2.07238677 |
| 76 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.07238677 |
| 77 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.07238677 |
| 78 | Reticulocytosis (HP:0001923) | 2.06417712 |
| 79 | Hyperammonemia (HP:0001987) | 2.05717210 |
| 80 | Mitral regurgitation (HP:0001653) | 2.04734643 |
| 81 | Hypolipoproteinemia (HP:0010981) | 2.01174687 |
| 82 | Neuronal loss in central nervous system (HP:0002529) | 2.00799099 |
| 83 | Supernumerary nipples (HP:0002558) | 2.00786682 |
| 84 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.99691543 |
| 85 | Pointed chin (HP:0000307) | 1.98071194 |
| 86 | Emphysema (HP:0002097) | 1.96369895 |
| 87 | Mediastinal lymphadenopathy (HP:0100721) | 1.96250208 |
| 88 | Periodontitis (HP:0000704) | 1.96235709 |
| 89 | Long palpebral fissure (HP:0000637) | 1.95958688 |
| 90 | Hypercholesterolemia (HP:0003124) | 1.95746921 |
| 91 | Abnormality of the radial head (HP:0003995) | 1.95249591 |
| 92 | Large earlobe (HP:0009748) | 1.94691790 |
| 93 | Axonal loss (HP:0003447) | 1.94363436 |
| 94 | Chronic obstructive pulmonary disease (HP:0006510) | 1.93007329 |
| 95 | Obstructive lung disease (HP:0006536) | 1.93007329 |
| 96 | Hemorrhage of the eye (HP:0011885) | 1.92825869 |
| 97 | Slender build (HP:0001533) | 1.91659096 |
| 98 | Abnormality of macrophages (HP:0004311) | 1.90680859 |
| 99 | Inflammation of the large intestine (HP:0002037) | 1.90075382 |
| 100 | Vacuolated lymphocytes (HP:0001922) | 1.89787561 |
| 101 | 11 pairs of ribs (HP:0000878) | 1.89669467 |
| 102 | Increased cerebral lipofuscin (HP:0011813) | 1.88902026 |
| 103 | Upper limb amyotrophy (HP:0009129) | 1.87679651 |
| 104 | Distal upper limb amyotrophy (HP:0007149) | 1.87679651 |
| 105 | Hypoplastic pelvis (HP:0008839) | 1.86830862 |
| 106 | Ectopia lentis (HP:0001083) | 1.86753277 |
| 107 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.86592314 |
| 108 | Striae distensae (HP:0001065) | 1.86358371 |
| 109 | Lymphangioma (HP:0100764) | 1.85890248 |
| 110 | Ankle clonus (HP:0011448) | 1.84542488 |
| 111 | Biconcave vertebral bodies (HP:0004586) | 1.84131220 |
| 112 | Bronchomalacia (HP:0002780) | 1.83517573 |
| 113 | Mitral valve prolapse (HP:0001634) | 1.83292760 |
| 114 | Supranuclear gaze palsy (HP:0000605) | 1.83008375 |
| 115 | Blue sclerae (HP:0000592) | 1.82699278 |
| 116 | Genu recurvatum (HP:0002816) | 1.82349327 |
| 117 | Narrow palate (HP:0000189) | 1.81057280 |
| 118 | Gastrointestinal infarctions (HP:0005244) | 1.80092625 |
| 119 | Broad metatarsal (HP:0001783) | 1.79928161 |
| 120 | Flared iliac wings (HP:0002869) | 1.79923586 |
| 121 | Macroorchidism (HP:0000053) | 1.79339274 |
| 122 | Agammaglobulinemia (HP:0004432) | 1.78478068 |
| 123 | Hyperbilirubinemia (HP:0002904) | 1.78270802 |
| 124 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.77728298 |
| 125 | Spinal canal stenosis (HP:0003416) | 1.77061355 |
| 126 | Ulnar bowing (HP:0003031) | 1.76903734 |
| 127 | Spinal cord lesions (HP:0100561) | 1.76770881 |
| 128 | Syringomyelia (HP:0003396) | 1.76770881 |
| 129 | Glomerulonephritis (HP:0000099) | 1.76752477 |
| 130 | Generalized hyperpigmentation (HP:0007440) | 1.76124417 |
| 131 | Growth hormone excess (HP:0000845) | 1.75971749 |
| 132 | Abnormality of the peritoneum (HP:0002585) | 1.75462586 |
| 133 | Chronic otitis media (HP:0000389) | 1.75405805 |
| 134 | Cupped ribs (HP:0000887) | 1.74732433 |
| 135 | Hypoalphalipoproteinemia (HP:0003233) | 1.73872697 |
| 136 | Meningitis (HP:0001287) | 1.73828750 |
| 137 | Aneurysm (HP:0002617) | 1.73311730 |
| 138 | Orchitis (HP:0100796) | 1.73164238 |
| 139 | Spondylolisthesis (HP:0003302) | 1.70272572 |
| 140 | Atelectasis (HP:0100750) | 1.70186379 |
| 141 | Vertebral compression fractures (HP:0002953) | 1.70137647 |
| 142 | Opisthotonus (HP:0002179) | 1.68747717 |
| 143 | Cervical subluxation (HP:0003308) | 1.68478912 |
| 144 | Symptomatic seizures (HP:0011145) | 1.67742604 |
| 145 | Megalencephaly (HP:0001355) | 1.67075696 |
| 146 | Hypoplasia of the thymus (HP:0000778) | 1.66514319 |
| 147 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.65924822 |
| 148 | Abnormality of the fingertips (HP:0001211) | 1.65894887 |
| 149 | Thoracic kyphosis (HP:0002942) | 1.65893179 |
| 150 | Epistaxis (HP:0000421) | 1.65589331 |
| 151 | Hypertriglyceridemia (HP:0002155) | 1.64970373 |
| 152 | Abnormality of the lumbar spine (HP:0100712) | 1.64836054 |
| 153 | Gingivitis (HP:0000230) | 1.64285263 |
| 154 | Recurrent abscess formation (HP:0002722) | 1.64058275 |
| 155 | Congenital glaucoma (HP:0001087) | 1.63353434 |
| 156 | Bladder diverticulum (HP:0000015) | 1.62477523 |
| 157 | Abnormality of methionine metabolism (HP:0010901) | 1.61198729 |
| 158 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.60674523 |
| 159 | Deep palmar crease (HP:0006191) | 1.60667979 |
| 160 | Amyloidosis (HP:0011034) | 1.58367225 |
| 161 | Abnormal gallbladder physiology (HP:0012438) | 1.58068526 |
| 162 | Cholecystitis (HP:0001082) | 1.58068526 |
| 163 | Ankle contracture (HP:0006466) | 1.57978893 |
| 164 | Abnormality of iron homeostasis (HP:0011031) | 1.57838068 |
| 165 | Prominent metopic ridge (HP:0005487) | 1.57400804 |
| 166 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.57103952 |
| 167 | Colitis (HP:0002583) | 1.56947808 |
| 168 | Adactyly (HP:0009776) | 1.56795260 |
| 169 | Recurrent bacterial skin infections (HP:0005406) | 1.56022017 |
| 170 | Increased serum ferritin (HP:0003281) | 1.55279301 |
| 171 | Hallux valgus (HP:0001822) | 1.54735613 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FGFR2 | 3.71329527 |
| 2 | TRIB3 | 3.30818512 |
| 3 | FGFR4 | 3.28603558 |
| 4 | SIK1 | 3.25869843 |
| 5 | ERN1 | 3.10966126 |
| 6 | PASK | 3.05896602 |
| 7 | MAP3K10 | 3.02130267 |
| 8 | BRD4 | 2.78072537 |
| 9 | PRPF4B | 2.63467362 |
| 10 | SMG1 | 2.29720058 |
| 11 | TYRO3 | 2.03626127 |
| 12 | PDGFRA | 1.98501427 |
| 13 | SIK3 | 1.94499725 |
| 14 | TAOK3 | 1.88066634 |
| 15 | ITK | 1.84783753 |
| 16 | SIK2 | 1.82914915 |
| 17 | TNK2 | 1.82485799 |
| 18 | PKN2 | 1.79563421 |
| 19 | CDK12 | 1.74034361 |
| 20 | EPHB1 | 1.65297869 |
| 21 | MAP3K13 | 1.58469211 |
| 22 | MAP3K11 | 1.53870114 |
| 23 | EEF2K | 1.51131868 |
| 24 | TLK1 | 1.50990595 |
| 25 | INSRR | 1.42691190 |
| 26 | ICK | 1.42194252 |
| 27 | RIPK4 | 1.35571068 |
| 28 | BLK | 1.32832255 |
| 29 | HIPK2 | 1.32823999 |
| 30 | PTK6 | 1.32255846 |
| 31 | BCKDK | 1.29858044 |
| 32 | CDC42BPA | 1.28996442 |
| 33 | NTRK2 | 1.28796210 |
| 34 | MAP4K1 | 1.28330109 |
| 35 | IRAK4 | 1.26507689 |
| 36 | RPS6KA4 | 1.23040510 |
| 37 | TYK2 | 1.19816915 |
| 38 | CAMK1G | 1.14640502 |
| 39 | FGFR3 | 1.14520980 |
| 40 | TESK2 | 1.13381193 |
| 41 | MAP3K6 | 1.12968782 |
| 42 | GRK6 | 1.09348055 |
| 43 | FES | 1.08826310 |
| 44 | FGFR1 | 1.08716289 |
| 45 | CAMKK1 | 1.05154333 |
| 46 | MAP2K6 | 1.01513480 |
| 47 | JAK3 | 1.01004430 |
| 48 | DYRK1B | 1.00112446 |
| 49 | NEK9 | 0.99693313 |
| 50 | PDPK1 | 0.97361982 |
| 51 | CSF1R | 0.93601297 |
| 52 | TTN | 0.93390499 |
| 53 | MAPK12 | 0.91969163 |
| 54 | TAOK1 | 0.91337049 |
| 55 | UHMK1 | 0.89364096 |
| 56 | IRAK3 | 0.88936296 |
| 57 | PRKD1 | 0.88150329 |
| 58 | KSR1 | 0.86937488 |
| 59 | NTRK1 | 0.85574665 |
| 60 | MAP3K1 | 0.85504795 |
| 61 | PTK2 | 0.84572929 |
| 62 | MTOR | 0.83210469 |
| 63 | RPS6KC1 | 0.82853952 |
| 64 | RPS6KL1 | 0.82853952 |
| 65 | BTK | 0.82603426 |
| 66 | EPHB2 | 0.81712988 |
| 67 | MAP3K14 | 0.81461471 |
| 68 | NME2 | 0.80766704 |
| 69 | EIF2AK3 | 0.76347492 |
| 70 | PDK1 | 0.73568416 |
| 71 | JAK1 | 0.73285763 |
| 72 | PRKD3 | 0.72128829 |
| 73 | DDR2 | 0.68173134 |
| 74 | RPS6KA6 | 0.67753653 |
| 75 | RET | 0.65434000 |
| 76 | HCK | 0.65179966 |
| 77 | MAPK7 | 0.64488659 |
| 78 | MARK2 | 0.63871692 |
| 79 | PTK2B | 0.63807284 |
| 80 | FLT3 | 0.62779914 |
| 81 | PKN1 | 0.62680033 |
| 82 | CAMK1D | 0.61259054 |
| 83 | SCYL2 | 0.61047492 |
| 84 | PAK6 | 0.60831290 |
| 85 | JAK2 | 0.59641726 |
| 86 | DAPK3 | 0.59283519 |
| 87 | PAK2 | 0.58763759 |
| 88 | MAP2K2 | 0.58307682 |
| 89 | CHUK | 0.58035061 |
| 90 | BMX | 0.57120092 |
| 91 | MAP3K3 | 0.55678712 |
| 92 | PDGFRB | 0.55132514 |
| 93 | CDK6 | 0.54363177 |
| 94 | MAP2K4 | 0.54268141 |
| 95 | KSR2 | 0.54142487 |
| 96 | MAPK11 | 0.53503068 |
| 97 | ZAP70 | 0.53073638 |
| 98 | CCNB1 | 0.53041042 |
| 99 | ILK | 0.52254048 |
| 100 | BCR | 0.51318247 |
| 101 | PAK3 | 0.50279989 |
| 102 | RPS6KA2 | 0.49348204 |
| 103 | PRKCZ | 0.49241622 |
| 104 | IKBKE | 0.49224100 |
| 105 | IRAK2 | 0.48889675 |
| 106 | TBK1 | 0.48722412 |
| 107 | MARK3 | 0.48329269 |
| 108 | TAOK2 | 0.48204381 |
| 109 | CSNK1A1L | 0.47308101 |
| 110 | CDK9 | 0.46873709 |
| 111 | LRRK2 | 0.45876101 |
| 112 | LCK | 0.45781029 |
| 113 | DYRK3 | 0.43303210 |
| 114 | KIT | 0.42456139 |
| 115 | FGR | 0.42339563 |
| 116 | TESK1 | 0.42055874 |
| 117 | MAPKAPK3 | 0.41756735 |
| 118 | SYK | 0.40625115 |
| 119 | PRKCQ | 0.40622616 |
| 120 | IKBKB | 0.39759495 |
| 121 | MAP2K3 | 0.37936578 |
| 122 | PRKCH | 0.37478285 |
| 123 | LYN | 0.37343980 |
| 124 | EPHA2 | 0.36766491 |
| 125 | MAPK3 | 0.36576290 |
| 126 | WNK1 | 0.36381279 |
| 127 | RIPK1 | 0.36072086 |
| 128 | CDK4 | 0.35925426 |
| 129 | MAP3K7 | 0.35468678 |
| 130 | MAPK15 | 0.35290665 |
| 131 | PRKD2 | 0.34680959 |
| 132 | RPS6KA1 | 0.34509681 |
| 133 | FYN | 0.34209591 |
| 134 | CSK | 0.34200727 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.08479669 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.80134981 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.32435490 |
| 4 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.23008514 |
| 5 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 3.11912814 |
| 6 | Sulfur relay system_Homo sapiens_hsa04122 | 2.59099479 |
| 7 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.52041845 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.20383730 |
| 9 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.16383449 |
| 10 | Lysine degradation_Homo sapiens_hsa00310 | 2.14848368 |
| 11 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.12127784 |
| 12 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.09746956 |
| 13 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.06991256 |
| 14 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.03075695 |
| 15 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.99005242 |
| 16 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.98749573 |
| 17 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.92883421 |
| 18 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.84490232 |
| 19 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.77404900 |
| 20 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.72199827 |
| 21 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.67471574 |
| 22 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.57711528 |
| 23 | Protein export_Homo sapiens_hsa03060 | 1.57350434 |
| 24 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.57034929 |
| 25 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.56265631 |
| 26 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.54867082 |
| 27 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.35912589 |
| 28 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.30487150 |
| 29 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.30081723 |
| 30 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.28715774 |
| 31 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.25522930 |
| 32 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.25464930 |
| 33 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.18709705 |
| 34 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.18317960 |
| 35 | Histidine metabolism_Homo sapiens_hsa00340 | 1.16449019 |
| 36 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.15984231 |
| 37 | Tuberculosis_Homo sapiens_hsa05152 | 1.12893524 |
| 38 | Allograft rejection_Homo sapiens_hsa05330 | 1.12878237 |
| 39 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.08142447 |
| 40 | Bile secretion_Homo sapiens_hsa04976 | 1.07576471 |
| 41 | Influenza A_Homo sapiens_hsa05164 | 1.06791719 |
| 42 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.06566036 |
| 43 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.06228207 |
| 44 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.05897331 |
| 45 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.05500175 |
| 46 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.04654393 |
| 47 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.04430104 |
| 48 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.04170895 |
| 49 | Peroxisome_Homo sapiens_hsa04146 | 1.02283407 |
| 50 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.01226839 |
| 51 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.01016995 |
| 52 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.99678612 |
| 53 | Hepatitis C_Homo sapiens_hsa05160 | 0.97879765 |
| 54 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.95790963 |
| 55 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.95485382 |
| 56 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.94875041 |
| 57 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.94404944 |
| 58 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.93414750 |
| 59 | Prion diseases_Homo sapiens_hsa05020 | 0.90494118 |
| 60 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.87795005 |
| 61 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.86133604 |
| 62 | ABC transporters_Homo sapiens_hsa02010 | 0.86121872 |
| 63 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.85093825 |
| 64 | Endometrial cancer_Homo sapiens_hsa05213 | 0.84950782 |
| 65 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.84753299 |
| 66 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.84528881 |
| 67 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.84243812 |
| 68 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.83532116 |
| 69 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.82821860 |
| 70 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.81770969 |
| 71 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.81105116 |
| 72 | Insulin resistance_Homo sapiens_hsa04931 | 0.80804721 |
| 73 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.80506370 |
| 74 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.80355572 |
| 75 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.79634259 |
| 76 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.78917731 |
| 77 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.78702171 |
| 78 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.77857519 |
| 79 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.77473471 |
| 80 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.77359453 |
| 81 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.77341883 |
| 82 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.75826390 |
| 83 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.75103621 |
| 84 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.74623182 |
| 85 | Endocytosis_Homo sapiens_hsa04144 | 0.73461353 |
| 86 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.73180431 |
| 87 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.71789524 |
| 88 | Asthma_Homo sapiens_hsa05310 | 0.71655821 |
| 89 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.70795684 |
| 90 | Bladder cancer_Homo sapiens_hsa05219 | 0.70046624 |
| 91 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.69933393 |
| 92 | Amoebiasis_Homo sapiens_hsa05146 | 0.69253232 |
| 93 | Apoptosis_Homo sapiens_hsa04210 | 0.68928503 |
| 94 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.67625871 |
| 95 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.65869497 |
| 96 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.65797801 |
| 97 | Lysosome_Homo sapiens_hsa04142 | 0.65566648 |
| 98 | Other glycan degradation_Homo sapiens_hsa00511 | 0.65375510 |
| 99 | Galactose metabolism_Homo sapiens_hsa00052 | 0.65336196 |
| 100 | Carbon metabolism_Homo sapiens_hsa01200 | 0.64884084 |
| 101 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.64779333 |
| 102 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.64345083 |
| 103 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.64286220 |
| 104 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.63287503 |
| 105 | Malaria_Homo sapiens_hsa05144 | 0.63044111 |
| 106 | Platelet activation_Homo sapiens_hsa04611 | 0.62848949 |
| 107 | HTLV-I infection_Homo sapiens_hsa05166 | 0.62647428 |
| 108 | Viral myocarditis_Homo sapiens_hsa05416 | 0.62556113 |
| 109 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.62525521 |
| 110 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.61276164 |
| 111 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.60644133 |
| 112 | Measles_Homo sapiens_hsa05162 | 0.59769855 |
| 113 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.59173965 |
| 114 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.58428549 |
| 115 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.57941017 |
| 116 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.57678612 |
| 117 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.57401704 |
| 118 | Colorectal cancer_Homo sapiens_hsa05210 | 0.57344558 |
| 119 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.56667633 |
| 120 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.55642075 |
| 121 | Salmonella infection_Homo sapiens_hsa05132 | 0.55014153 |
| 122 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.53605656 |
| 123 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.53464051 |
| 124 | Phagosome_Homo sapiens_hsa04145 | 0.53221950 |
| 125 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.52828816 |
| 126 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.52244414 |
| 127 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.51698745 |
| 128 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.51536709 |
| 129 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.50962215 |
| 130 | Long-term potentiation_Homo sapiens_hsa04720 | 0.50906208 |
| 131 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.50579982 |
| 132 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.50352242 |
| 133 | Glioma_Homo sapiens_hsa05214 | 0.49671131 |
| 134 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.49451110 |
| 135 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.49259060 |
| 136 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.49255616 |
| 137 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.45447278 |
| 138 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.43173963 |
| 139 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.43136122 |
| 140 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.42685195 |
| 141 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.42499206 |
| 142 | Retinol metabolism_Homo sapiens_hsa00830 | 0.41939096 |
| 143 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.40121479 |
| 144 | Leishmaniasis_Homo sapiens_hsa05140 | 0.34925938 |
| 145 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.33375239 |
| 146 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.32862796 |
| 147 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.31006933 |
| 148 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.30525649 |
| 149 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.30502411 |
| 150 | Prostate cancer_Homo sapiens_hsa05215 | 0.30084763 |
| 151 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.28165735 |
| 152 | Hepatitis B_Homo sapiens_hsa05161 | 0.27265953 |
| 153 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.25387623 |
| 154 | Pertussis_Homo sapiens_hsa05133 | 0.24643657 |
| 155 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.24095059 |
| 156 | Cocaine addiction_Homo sapiens_hsa05030 | 0.24035727 |
| 157 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.23349112 |
| 158 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.21566842 |
| 159 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.20363529 |
| 160 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.19164472 |

